Maryland House Bill 1107 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 5 2021 - 25% progression, died in committee
Action: 2021-02-11 - Hearing 3/02 at 1:30 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]

Requiring, on or before December 1, 2021, the Maryland Department of Health to apply to the Centers for Medicare and Medicaid Services for a State plan amendment that authorizes the State to enter into value-based arrangements with drug manufacturers through supplemental rebate agreements and seeks an approval that authorizes a subscription model for hepatitis C therapies; requiring, to the extent possible, the Maryland Department of Health, in collaboration certain other State agencies, to develop a certain subscription model; etc.

Maryland Medical Assistance Program - Supplemental Rebate Program - Subscription Model for Hepatitis C Therapies

Del. Terri Hill [D]

Date	Chamber	Action
2021-02-11	House	Hearing 3/02 at 1:30 p.m.
2021-02-05	House	First Reading Health and Government Operations

Chapter	Article	Section	Citation Type	Statute Text
Health - General	15	119	(n/a)	See Bill Text

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1107?ys=2021RS
Text	https://mgaleg.maryland.gov/2021RS/bills/hb/hb1107f.pdf